Literature DB >> 11310590

Synthesis of 2-amido-3-hydroxypyridin-4(1H)-ones: novel iron chelators with enhanced pFe3+ values.

Z D Liu1, S Piyamongkol, D Y Liu, H H Khodr, S L Lu, R C Hider.   

Abstract

The synthesis of a range of 2-amido-3-hydroxypyridin-4-ones as bidentate iron(III) chelators with potential for oral administration is described. The pKa values of the ligands together with the stability constants of their iron(III) complexes have been determined. Results indicate that the introduction of an amido substituent at the 2-position leads to an appreciable enhancement of the pFe3+ values. The ability of these novel 3-hydroxypyridin-4-ones to facilitate the iron excretion in bile was investigated using a 59Fe-ferritin loaded rat model. The optimal effect was observed with the N-methyl amido derivative 15b, which has an associated pFe3+ value of 21.7, more than two orders of magnitude higher than that of deferiprone (1,2-dimethyl-3-hydroxypyridin-4-one) 1a (pFe3+ = 19.4). Dose response studies suggest that chelators with high pFe3+ values scavenge iron more effectively at lower doses when compared with simple dialkyl substituted hydroxypyridinones.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11310590     DOI: 10.1016/s0968-0896(00)00273-x

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

1.  Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

Authors:  Jennifer A Jacobsen; Jessica L Fullagar; Melissa T Miller; Seth M Cohen
Journal:  J Med Chem       Date:  2010-12-28       Impact factor: 7.446

2.  Chelation and determination of labile iron in primary hepatocytes by pyridinone fluorescent probes.

Authors:  Yongmin Ma; Herbert de Groot; Zudong Liu; Robert C Hider; Frank Petrat
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

3.  Investigation of the complexation of natZr(iv) and 89Zr(iv) by hydroxypyridinones for the development of chelators for PET imaging applications.

Authors:  F Guérard; M Beyler; Y-S Lee; R Tripier; J-F Gestin; M W Brechbiel
Journal:  Dalton Trans       Date:  2017-04-05       Impact factor: 4.390

4.  Synthesis of hydroxypyrone- and hydroxythiopyrone-based matrix metalloproteinase inhibitors: developing a structure-activity relationship.

Authors:  Yi-Long Yan; Melissa T Miller; Yuchen Cao; Seth M Cohen
Journal:  Bioorg Med Chem Lett       Date:  2009-02-14       Impact factor: 2.823

5.  Efficient synthesis of 5-amido-3-hydroxy-4-pyrones as inhibitors of matrix metalloproteinases.

Authors:  Yi-Long Yan; Seth M Cohen
Journal:  Org Lett       Date:  2007-05-24       Impact factor: 6.005

6.  Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1.

Authors:  Michael J Capper; Paul M O'Neill; Nicholas Fisher; Richard W Strange; Darren Moss; Stephen A Ward; Neil G Berry; Alexandre S Lawrenson; S Samar Hasnain; Giancarlo A Biagini; Svetlana V Antonyuk
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-06       Impact factor: 11.205

7.  Preparation and quality control of the [sm]-samarium maltolate complex as a lanthanide mobilization product in rats.

Authors:  Zohreh Naseri; Amir Hakimi; Amir R Jalilian; Ali Nemati Kharat; Ali Bahrami-Samani; Mohammad Ghannadi-Maragheh
Journal:  Sci Pharm       Date:  2011-02-24

8.  Synthesis and Validation of a Hydroxypyrone-Based, Potent, and Specific Matrix Metalloproteinase-12 Inhibitor with Anti-Inflammatory Activity In Vitro and In Vivo.

Authors:  J Aerts; R E Vandenbroucke; R Dera; S Balusu; E Van Wonterghem; L Moons; C Libert; W Dehaen; L Arckens
Journal:  Mediators Inflamm       Date:  2015-08-13       Impact factor: 4.711

9.  Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B.

Authors:  Michelle T Ma; Levente K Meszaros; Brett M Paterson; David J Berry; Maggie S Cooper; Yongmin Ma; Robert C Hider; Philip J Blower
Journal:  Dalton Trans       Date:  2015-03-21       Impact factor: 4.390

Review 10.  Desferrithiocin: a search for clinically effective iron chelators.

Authors:  Raymond J Bergeron; Jan Wiegand; James S McManis; Neelam Bharti
Journal:  J Med Chem       Date:  2014-09-10       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.